Search Results 1071-1080 of 19052 for corticosteroid

  1. Dendritic Cell Therapy, Cryosurgery, and Pembrolizumab in Treating Patients With Non-Hodgkin Lymphoma - Mayo Clinic

    Corticosteroid use ≤ 2 weeks prior to registration. NOTE: patients must be off corticosteroids for at least 2 weeks prior to registration; this includes ...

  2. A Study To Evaluate Pembrolizumab With Standard Therapy To Treat Newly-diagnosed Glioblastoma - Mayo Clinic

    ... corticosteroids or immunosuppressive drugs). ... NOTE: Replacement therapy (e.g., thyroxine, insulin, or physiologic corticosteroid replacement therapy for ...

  3. Triamcinolone (nasal route) - Side effects & dosage - Mayo Clinic

    Triamcinolone nasal spray is used to treat an itchy or runny nose, sneezing, or other symptoms caused by seasonal and perennial hay fever (allergic rhinitis).

  4. A Study to Better Understand the Immune Response to the Flu Vaccine (MF59) and the High Dose Flu Vaccine (HDFlu) in People 65 Years of Age and Older - Mayo Clinic

    Subjects on corticosteroids will be excluded if ≥ 20mg ... Subjects will be eligible if corticosteroid therapyhas been discontinued for at least 30 days.

  5. A Study Of Mogamulizumab Combined With Nivolumab In Patients Who Have Locally Advanced Or Metastatic Solid Tumors - Mayo Clinic

    ... corticosteroids;; These include but are not limited to subjects with a ... corticosteroids are eligible;; Subject with psoriasis controlled with topical ...

  6. An Extension Study Of Subjects Who Received An Avalyn Inhaled Antifibrotic Agent (SAIL) - Mayo Clinic

    * Subjects who experienced an exacerbation of asthma or of chronic obstructive pulmonary disease (COPD) requiring oral or systemic corticosteroids within 3 ...

  7. Expanded Access Program With Nivolumab (BMS-936558) in Combination With Ipilimumab (Yervoy®) in Anti-CTLA-4 Treatment-Naïve Subjects With Unresectable or Metastatic Melanoma (CheckMate 218) - Mayo Clinic

    Subjects with a condition requiring systemic treatment with either corticosteroids (>10 mg daily prednisone equivalents) or other immunosuppressive medications ...

  8. Hypertrophic cardiomyopathy - Doctors and departments - Mayo Clinic

    In this condition, the heart muscle thickens, which makes it harder for the heart to pump blood. Learn about the causes and treatment.

  9. Study Of Tirabrutinib Vs Rituximab/Temozolomide For Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL) - Mayo Clinic

    Concomitant systemic corticosteroid exposure within 14 days before starting study drug per Investigator assessment with the exception of the following: * ...

  10. Calciphylaxis - Diagnosis and treatment - Mayo Clinic

    These triggers include warfarin, corticosteroids and iron. If you take calcium or vitamin D supplements, your healthcare professional may change the amount ...